New CEO of Bionor Pharma ASA

By Emily Deckelman on August 30, 2010

NEWS: Henrik Lund MD PhD, Former Global VP in Clinical Development at Astra Zeneca, Named New CEO of Bionor Pharma ASA

{0 comments add one}

Early Vacc-4x Results

By Emily Deckelman on August 30, 2010

NEWS: Two Thirds of Study Volunteers Respond to First-Ever “Re-Vaccination” of Vacc-4x

{0 comments add one}

Bionor Immuno’s Therapeutic HIV Vaccine Candidate Vacc-4x

By Emily Deckelman on July 22, 2010

NEWS: Bionor Immuno’s Therapeutic HIV Vaccine Candidate Vacc-4x Targeting Conserved Domains of HIV Produce Immune Response Seven Years After Inoculation

{0 comments add one}

Four Therapeutic Vaccines Show Efficacy

By Emily Deckelman on July 22, 2010

NEWS: Four Therapeutic Vaccines Show Efficacy; Other Leading Therapeutic HIV Vaccines, Anti-Immune Hyperactivation, and Immune-Based Therapies Hit Milestones

{0 comments add one}

NutriPharma ASA and Subsidiary Bionor Immuno AS Change Name to Bionor Pharma ASA

By Emily Deckelman on May 27, 2010

NEWS: NutriPharma ASA and Subsidiary Bionor Immuno AS Change Name to Bionor Pharma ASA.

{0 comments add one}